Concord Health Partners, a healthcare-focused investment firm, has closed its Concord Innovation Fund II with $150 million in commitments.

The fund will focus on growth investments and looks to invest in healthcare companies with technologies and services that aim to enhance the value of care through lower costs, improved quality and expanded access. To date, the fund has invested in six portfolio companies, including Clarify Health, Loyal, Iris, Accelus and Mindmaze.

“We are honored by the support we have received from both existing and new LPs as we work with our partners to identify and accelerate the growth of innovative companies that advance healthcare,” comments James Olsen, founder and managing partner at Concord. “The substantial increase in capital raised and LP participation in Fund II is a testament to our strategy and follows the recent growth of our senior team and the establishment of a Nashville office, better positioning the firm to identify and diligence new platform opportunities. The pipeline of innovation within the healthcare ecosystem remains robust, and we are excited to put this capital to work for the benefit of our investor base.”